Assessing Diabetes Mellitus on Cytokine Analysis and Macular Edema Following FLACS

NCT04856670 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2021-05-12

No results posted yet for this study

Summary

The purpose of this study is to assess the effects of diabetes mellitus (DM) on anterior chamber cytokine production and postoperative macular edema in patients undergoing femtosecond laser-assisted cataract surgery (FLACS). Patients with DM routinely undergo FLACS, yet the majority of studies evaluating intraocular inflammation following femtosecond laser treatment have excluded this patient population. Importantly, DM alters the inflammatory status of the eye, which may influence the production of inflammatory mediators following femtosecond laser treatment and the development of postoperative macular edema. The results from this study will provide insight into the risks and benefits of FLACS in patients with DM.

Conditions

Interventions

PROCEDURE

Cataract surgery

Cataract surgery- Manual or femtosecond laser assisted

Sponsors & Collaborators

  • Uptown Eye Specialists

    lead OTHER

Principal Investigators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-25
Primary Completion
2021-09-15
Completion
2021-09-15

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04856670 on ClinicalTrials.gov